×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
山东大学 [5]
复旦大学上海医学院 [4]
中国医学科学院 北京... [3]
上海健康医学院 [2]
厦门大学 [1]
兰州大学 [1]
更多...
内容类型
期刊论文 [16]
会议论文 [2]
学位论文 [1]
发表日期
2018 [1]
2017 [1]
2016 [1]
2015 [4]
2013 [1]
2012 [1]
更多...
学科主题
biochemist... [1]
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共19条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Association analysis of interleukin-18 gene promoter region polymorphisms and susceptibility to sporadic breast cancer in Chinese Han women
期刊论文
2018, 卷号: 32, 期号: 9, 页码: e22591
作者:
Qiao, Xuefeng
;
Xu, Danfei
;
Sun, Dandan
;
Sun, Sijin
;
Huang, Zhiping
收藏
  |  
浏览/下载:9/0
  |  
提交时间:2020/01/03
breast cancer
interleukin-18
polymorphism
susceptibility
FOXC1 overexpression is a marker of poor response to anthracycline-based adjuvant chemotherapy in sporadic triple-negative breast cancer
期刊论文
2017, 卷号: 79, 期号: 6, 页码: 1205-1213
作者:
Xu Y L
;
Yao R
;
Li J
;
Zhou Y D
;
Mao F
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2020/01/04
FOXC1
Anthracycline
Chemosensitivity
Prognosis
TNBC
Association between genetic variants of EGF-containing fibulin-like extracellular matrix protein1 gene and sporadic breast cancer in a Chinese Han population
期刊论文
EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2016, 卷号: 37, 期号: 1
作者:
Li, X.
;
Quan, Y.
;
Tang, C.
;
Chen, Y.
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2019/12/13
EFEMP1 gene
Single nucleotide polymorphism
Genetic susceptibility
Molecular biology
Breast cancer
DNA Repair Genes XRCC1 and ERCC1 Polymorphisms and the Risk of Sporadic Breast Cancer in Han Women in the Gansu Province of China
期刊论文
GENETIC TESTING AND MOLECULAR BIOMARKERS, 2015, 卷号: 19, 期号: 7, 页码: 387-393
作者:
Zhu, GJ
;
Wang, L
;
Guo, HY
;
Lu, LG
;
Yang, SS
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2017/01/13
Clinicopathological significance and potential drug target of CDH1 in breast cancer: a meta-analysis and literature review
期刊论文
Drug Design, Development and Therapy, 2015, 卷号: 9, 页码: 5277-5285
作者:
Huang, Ruixue
;
Ding, Ping
;
Yang, Fei*
收藏
  |  
浏览/下载:15/0
  |  
提交时间:2019/12/03
CDH1
as a tumor suppressor gene
contributes sporadic breast cancer (BC) progression. However
the association between CDH1 hypermethylation and BC
and its clinicopathological significance remains unclear. We conducted a meta-analysis to investigate the relationship between the CDH1 methylation profile and the major clinicopathological features. A detailed literature was searched through the electronic databases PubMed
Web of Science™
and EMBASE™ for related research publications. The data were extracted and assessed by two reviewers independently. Odds ratios (ORs) with corresponding confidence intervals (CIs) were calculated and summarized respectively. The frequency of CDH1 methylation was significantly higher in invasive ductal carcinoma than in normal breast tissues (OR =5.83
95% CI 3.76–9.03
P<0.00001). CDH1 hypermethylation was significantly higher in estrogen receptor (ER)-negative BC than in ER-positive BC (OR =0.62
95% CI 0.43–0.87
P=0.007). In addition
we found that the CDH1 was significantly methylated in HER2-negative BC than in HER2-positive BC (OR =0.26
95% CI 0.15–0.44
P<0.00001). However
CDH1 methylation frequency was not associated with progesterone receptor (PR) status
or with grades
stages
or lymph node metastasis of BC patients. Our results indicate that CDH1 hypermethylation is a potential novel drug target for developing personalized therapy. CDH1 hypermethylation is strongly associated with ER-negative and HER2-negative BC
respectively
suggesting CDH1 methylation status could contribute to the development of novel therapeutic approaches for the treatment of ER-negative or HER2-negative BC with aggressive tumor biology.
The possible role of EZH2 and DNMT1 polymorphisms in sporadic triple-negative breast carcinoma in southern Chinese females
期刊论文
TUMOR BIOLOGY, 2015, 卷号: 36, 期号: 12
作者:
Tao, Ran
;
Chen, Zekun
;
Wu, Pingping
;
Liu, Cuicui
;
Peng, You
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2019/12/06
Triple-negative breast cancer
Single nucleotide polymorphism
EZH2
DNMT1
Hypermethylation of BRCA1 gene: implication for prognostic biomarker and therapeutic target in sporadic primary triple-negative breast cancer
期刊论文
2015, 卷号: 150, 期号: 3, 页码: 479-486
作者:
Zhu, X.
;
Shan, L.
;
Wang, F.
;
Wang, J.
;
Shen, G.
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2020/01/13
BRCA1
Promoter methylation
Triple-negative breast cancer
Prognosis
Gender-specific association of NFKBIA promoter polymorphisms with the risk of sporadic colorectal cancer
期刊论文
Medical oncology, 2013, 期号: 4, 页码: 1-6
作者:
Zheng,L.
;
Liang,W.
;
Guo,Q.
;
Liu,Y.
;
Roncati,L.
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2019/12/23
Colorectal cancer
Genetic association
NFKBIA
Sporadic
Susceptibility
Variation
Epstein-Barr Virus Infection and Sporadic Breast Cancer Risk: A Meta-Analysis
期刊论文
PLOS ONE, 2012, 卷号: 7, 期号: 2
作者:
Huo, Qiang
;
Zhang, Ning
;
Yang, Qifeng
收藏
  |  
浏览/下载:11/0
  |  
提交时间:2019/12/23
BRCA基因的克隆,表达与纯化
学位论文
2011, 2011
李振
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2016/02/14
乳腺癌易感基因
分子克隆
抗体
BRCA
molecular cloning
antibody
©版权所有 ©2017 CSpace - Powered by
CSpace